Archaeal 72-Membered Macrocyclic Tetraether Lipids
J . Org. Chem., Vol. 63, No. 8, 1998 2697
a 45 h period. After an additional 18 h reflux period, the
reaction mixture was cooled to room temperature and 20%
aqueous K2CO3 solution (30 mL) was added. The resulting
mixture was stirred for 4 h. The organic phase was separated,
and the aqueous phase was extracted 10 times with ether. The
combined organic extract was washed with saturated aqueous
NH4Cl and brine, dried (Na2SO4), filtered, and concentrated
to dryness. The residue was chromatographed over silica gel
with hexane-EtOAc (20:1) to give 24 (58 mg, 59%) as an oil:
[R]26D +7.08 (c 1.273, CHCl3); 1H NMR (300 MHz) δ 0.80-0.97
(m, 48H), 0.97-1.68 (m, 98H), 2.02 (m, 2H), 3.43-3.65 (m,
18H), 4.55 (s, 4H), 5.16 (dd, J ) 2.2, 4.6, 2H), 7.22-7.35 (m,
10H); 13C NMR (75 MHz) δ 19.74, 19.77, 19.80, 19.82, 21.33,
24.39 24.45, 24.50, 24.78, 29.76, 29.83, 32.77, 32.80, 32.82,
33.05, 34.29, 36.62, 36.83, 37.09, 37.35, 37.39, 37.45, 37.51,
37.59, 37.63, 68.81, 69.89, 70.30, 70.96, 73.35, 77.94, 127.49,
127.58, 128.30, 134.65, 138.41; IR (neat) 696, 733, 1115, 1377,
1458, 2858, 2925, 2951 cm-1; EI-MS m/z 1479 (M+), 1387, 1282,
91. Anal. Calcd for C100H182O6: C, 81.13; H, 12.39. Found:
C, 81.30; H, 12.50.
2,3′-O-[(3R,7R,11S,15S,18S,22S,26R,30R)-16-Acet oxy-
3,7,11,15,18,22,26,30-oct a m et h yl-17-(p h en ylsu lfon yl)d o-
tr ia con ta n e-1,32-d iyl]-2′,3-bis-O-[(3R,7R,11S,15S)-16-[(4-
m eth oxyben zyl)oxy]-3,7,11,15-tetr a m eth ylh exa d eca n yl-
]bis(1-O-ben zyl-sn -glycer ol) (27). Compound 26 (681 mg,
0.356 mmol) was treated in the same manner as described for
the preparation of 19 to give â-acetoxy sulfone 27 (503 mg,
72%) as an oil: 1H NMR (300 MHz) δ 0.72-0.97 (m, 48H),
0.97-1.80 (m, 95H), 2.04 (s, 1.1H), 2.07 (s, 0.9H), 2.09-2.35
(m, 1H), 2.11 (s, 0.7H), 2.15 (s, 0.3H), 3.14 (m, 0.35H), 3.20
(dd, J ) 6.8, 9.0 Hz, 2H), 3.30 (dd, J ) 6.1, 9.0 Hz, 2H), 3.36-
3.67 (m, 1.65H), 3.79 (s, 6H), 4.43 (s, 4H), 4.55 (s, 4H), 4.95-
5.06 (m, 0.33H), 5.18-5.21 (m, 0.67H), 6.87 (dt, J ) 8.8, 2.2
Hz, 4H), 7.22-7.35 (m, 14H), 7.56 (m, 2H), 7.64 (m, 1H), 7.93
(m, 2H); 13C NMR (75 MHz) δ 17.22, 19.68, 19.71, 19.76, 24.35,
24.46, 29.81, 29.89, 32.77, 32.81, 33.44, 34.01, 36.62, 37.09,
37.32, 37.38, 37.40, 37.53, 55.21, 68.87, 69.95, 70.30, 70.76,
72.58, 73.33, 75.73, 77.93, 113.67, 127.48, 127.56, 128.28,
128.83, 129.07, 129.12, 130.91, 138.42, 159.00; IR (neat) 696,
735, 820, 1038, 1099, 1111, 1248, 1306, 1377, 1462, 1514, 1612,
1747, 2858, 2925, 2951 cm-1. Anal. Calcd for C124H208O14S:
C, 76.18; H, 10.72. Found: C, 76.28; H, 10.91.
2,3′-O-[(3R,7R,11S,15S,18S,22S,26R,30R)-3,7,11,15,18,
22,26,30-Octa m eth yld otr ia con t-16-en e-1,32-d iyl]-2′,3-bis-
O-[(3R,7R,11S,15S)-16-[(4-m eth oxyben zyl)oxy]-3,7,11,15-
tetr am eth ylh exadecan yl]bis(1-O-ben zyl-sn -glycer ol) (28).
Compound 27 (493 mg, 0.252 mmol) was treated in the same
manner as described for the preparation of 20 to give oily 28
(385 mg, 87%) as a mixture of geometrical isomers (E/Z ) 85:
15): 1H NMR (300 MHz) δ 0.80-0.97 (m, 48H), 0.97-1.80 (m,
94H), 2.02 (m, 1.7H), 2.38 (m, 0.3H), 3.20 (dd, J ) 6.8, 9.0 Hz,
2H), 3.30 (dd, J ) 6.1, 9.0 Hz, 2H), 3.41-3.65 (m, 18H), 3.80
(s, 6H), 4.43 (s, 4H), 4.55 (s, 4H), 5.02 (dd, J ) 1.8, 7.2 Hz,
0.3H), 5.18 (dd, J ) 2.2, 4.7 Hz, 1.7H), 6.87 (dt, J ) 8.8, 2.2
Hz, 4H), 7.22-7.35 (m, 14H); 13C NMR (75 MHz) δ 17.21,
19.70, 19.75, 21.17, 24.35, 24.47, 24.50, 24.72, 29.81, 29.89,
31.57, 32.75, 32.78, 32.81, 33.44, 34.01, 36.63, 36.70, 37.09,
37.25, 37.39, 37.53, 55.21, 68.87, 69.95, 70.31, 70.77, 72.58,
73.33, 75.74, 77.94, 113.68, 127.47, 127.55, 128.27, 129.06,
130.91, 133.57, 134.56, 138.42, 159.00; IR (neat) 696, 735, 820,
1039, 1101, 1111, 1248, 1377, 1462, 1514, 1612, 2858, 2925,
2951 cm-1. Anal. Calcd for C116H200O10: C, 79.39; H, 11.49.
Found: C, 79.33; H, 11.79.
(2S ,7R ,11R ,15S ,19S ,22S ,26S ,30R ,34R ,39S ,43R ,47R ,
51S,55S,58S,62S,66R,70R)-2,39-Bis[(b en zyloxy)m et h yl]-
7,11,15,19,22,26,30,34,43,47,51,55,58,62,66,70-h exa d eca -
m eth yl-1,4,37,40-tetr aoxacyclodoh eptacon tan e (25). Com-
pound 24 (96 mg, 0.064 mmol) was treated in the same manner
as described for the preparation of 21 to give 25 (77 mg, 80%)
1
as an oil: [R]25 +1.61 (c 1.00, CHCl3); H NMR (300 MHz) δ
D
0.80-0.92 (m, 48H), 0.97-1.68 (m, 104H), 3.43-3.65 (m, 18H),
4.55 (s, 4H), 7.22-7.35 (m, 10H); 13C NMR (75 MHz) δ 19.76,
19.80, 19.82, 24.38, 24.46, 29.74, 29.84, 32.80, 32.82, 33.05,
34.30, 36.62, 37.05, 37.37, 37.46, 37.51, 68.79, 69.89, 70.31,
70.97, 73.35, 77.94, 127.49, 127.58, 128.30, 138.41; IR (neat)
696, 733, 1115, 1377, 1462, 2858, 2925, 2951 cm-1; EI-MS m/z
1481 (M+), 1389 (M+ - CH2Ph), 1284, 91. Anal. Calcd for
C
100H184O6: C, 81.01; H, 12.51. Found: C, 80.75; H, 12.69.
(2S ,7R ,11R ,15S ,19S ,22S ,26S ,30R ,34R ,39S ,43R ,47R ,
51S ,55S ,58S ,62S ,66R ,70R )-2,39-B is(h y d r o x ym e t h yl)-
7,11,15,19,22,26,30,34,43,47,51,55,58,62,66,70-h exa d eca -
m et h yl-1,4,37,40-t et r a oxa cyclod oh ep t a con t a n e (3a ).
A
mixture of 25 (73 mg, 0.049 mmol) and 10% Pd-C (22 mg) in
EtOAc (15 mL) was stirred for 3.5 h under an atmospheric
pressure of hydrogen at 40 °C. The mixture was filtered, and
the filtrate was concentrated to dryness. The residue was
chromatographed over silica gel with hexanes-EtOAc (5:1) to
2,3′-O-[(3R,7R,11S,15S,18S,22S,26R,30R)-3,7,11,15,18,
22,26,30-Oct a m et h yld ot r ia con t a n e-1,32-d iyl]-2′,3-b is-O-
[(3R,7R,11S,15S)-16-[(4-m eth oxyben zyl)oxy]-3,7,11,15-tet-
r a m eth ylh exa d eca n yl]bis(1-O-ben zyl-sn -glycer ol) (29).
Compound 28 (377 mg, 0.215 mmol) was treated in the same
manner as described for the preparation of 21 to give 29 (324
give 3a (50 mg, 78%) as an oil: [R]25 +8.68 (c 1.68, CHCl3);
D
1H NMR (300 MHz) δ 0.80-0.92 (m, 48H), 0.97-1.68 (m,
104H), 2.21 (br, 2H), 3.42-3.74 (m, 18H); 13C NMR (75 MHz)
δ 19.74, 19.80, 19.82, 24.34, 24.43, 29.75, 29.86, 32.75, 33.02,
34.26, 36.53, 37.01, 37.33, 37.48, 63.03, 68.56, 70.05, 71.02,
78.32; IR (neat) 1051, 1117, 1377, 1462, 2858, 2925, 2951, 3452
cm-1; EI-MS m/z 1301 (M+), 1283 (M+ - H2O), 1271, 650.
Anal. Calcd for C86H172O6: C, 79.32; H, 13.31. Found: C,
79.04; H, 13.60.
mg, 86%) as an oil: [R]23 +3.63 (c 0.420, CHCl3); 1H NMR
D
(300 MHz) δ 0.80-0.95 (m, 48H), 0.97-1.80 (m, 100H), 3.19
(dd, J ) 6.8, 9.0 Hz, 2H), 3.30 (dd, J ) 6.1, 9.0 Hz, 2H), 3.41-
3.65 (m, 18H), 3.80 (s, 6H), 4.43 (s, 4H), 4.55 (s, 4H), 6.87 (dt,
J ) 8.8, 2.2 Hz, 4H), 7.22-7.35 (m, 14H); 13C NMR (75 MHz)
δ 17.21, 19.68, 19.71, 19.76, 24.35, 24.48, 29.80, 29.88, 32.78,
32.81, 33.05, 33.44, 34.01, 34.31, 36.62, 37.09, 37.32, 37.38,
37.41, 37.52, 37.56, 55.22, 68.87, 69.95, 70.29, 70.76, 72.58,
73.33, 75.73, 77.92, 113.67, 127.48, 127.56, 128.28, 129.08,
130.91, 138.41, 158.99; IR (neat) 696, 733, 820, 1039, 1099,
2,3′-O-[(3R,7R,11S,15S,18S,22S,26R,30R)-16-H yd r oxy-
3,7,11,15,18,22,26,30-oct a m et h yl-17-(p h en ylsu lfon yl)d o-
tr ia con ta n e-1,32-d iyl]-2′,3-bis-O-[(3R,7R,11S,15S)-16-[(4-
m et h oxyb en zyl)oxy]-3,7,11,15-t et r a m et h ylh exa d eca n -
yl]bis(1-O-ben zyl-sn -glycer ol) (26). Sulfone 13 (700 mg,
0.686 mmol) and aldehyde 17 (559 mg, 0.625 mmol) were
treated in the same manner as described for the preparation
of 18 to give â-hydroxy sulfone 26 (700 mg, 59%) as an oil: 1H
NMR (300 MHz) δ 0.74-0.97 (m, 48H), 0.97-1.82 (m, 95H),
2.00-2.40 (m, 1H), 3.05-3.77 (m, 19.7H), 3.20 (dd, J ) 6.8,
9.0 Hz, 2H), 3.30 (dd, J ) 5.9, 9.0 Hz, 2H), 3.78 (s, 6H), 4.10
(m, 0.3H), 4.43 (s, 4H), 4.55 (s, 4H), 6.87 (dt, J ) 8.8, 2.2 Hz,
4H), 7.22-7.35 (m, 14H), 7.56 (m, 2H), 7.64 (m, 1H), 7.91 (m,
2H); 13C NMR (75 MHz) δ 17.20, 19.66, 19.69, 19.74, 24.34,
24.44, 29.79, 29.87, 32.75, 32.79, 33.43, 33.99, 36.61, 37.07,
37.30, 37.36, 37.51, 55.20, 68.85, 69.94, 70.29, 70.75, 72.56,
73.32, 75.72, 77.91, 113.65, 127.45, 127.54, 128.27, 128.32,
129.00, 129.06, 129.20, 138.40, 158.99; IR (neat) 696, 733, 820,
1039, 1099, 1111, 1248, 1302, 1377, 1462, 1514, 1612, 2856,
2925, 2951 cm-1. Anal. Calcd for C122H206O13S: C, 76.60; H,
10.85. Found: C, 76.54; H, 11.04.
1111, 1248, 1377, 1462, 1514, 1612, 2856, 2925, 2951 cm-1
.
Anal. Calcd for C116H202O10: C, 79.30; H, 11.59. Found: C,
79.05; H, 11.70.
2,3′-O-(3R,7R,11S,15S,18S,22S,26R,30R)-3,7,11,15,18,
22,26,30-Oct a m et h yld ot r ia con t a n e-1,32-d iyl]-2′,3-b is-O-
[(3R,7R,11S,15S)-16-h yd r oxy-3,7,11,15-tetr a m eth ylh exa -
d eca n yl]bis(1-O-b en zyl-sn -glycer ol) (30). Compound 29
(288 mg, 0.164 mmol) was treated in the same manner as
described for the preparation of 22 to give diol 30 (228 mg,
1
92%) as an oil: [R]23 +0.54 (c 0.580, CHCl3); H NMR (300
D
MHz) δ 0.80-0.94 (m, 48H), 0.97-1.72 (m, 100H), 3.37-3.64
(m, 22H), 4.55 (s, 4H), 7.22-7.35 (m, 10H); 13C NMR (75 MHz)
δ 16.63, 19.70, 19.76, 24.34, 24.39, 24.47, 29.79, 29.86, 32.73,
32.79, 33.03, 33.46, 34.30, 35.75, 36.60, 37.06, 37.28, 37.34,
37.41, 37.50, 37.55, 68.33, 68.86, 69.94, 70.26, 70.75, 73.32,
77.91, 127.47, 127.56, 128.27, 138.37; IR (neat) 696, 733, 1113,